CORC

在结果中检索

CORC

浏览/检索结果: 共26条，第1-10条 帮助

限定条件                
已选(0)清除 条数/页：   排序方式：
Discovery and evaluation of ZT55, a novel highly-selective tyrosine kinase inhibitor of JAK2 V617F against myeloproliferative neoplasms 期刊论文
Journal of Experimental and Clinical Cancer Research, 2019, 卷号: 38, 期号: 1
作者:  Hu M.;  Xu C.;  Yang C.;  Zuo H.;  Chen C.
收藏  |  浏览/下载：17/0  |  提交时间：2019/12/11
Trimetazidine ameliorates sunitinib-induced cardiotoxicity in mice via the AMPK/mTOR/autophagy pathway 期刊论文
PHARMACEUTICAL BIOLOGY, 2019, 卷号: 57, 期号: 1, 页码: 625-631
作者:  Yang, Yi;  Li, Na;  Chen, Tongshuai;  Zhang, Chunmei;  Liu, Lingxin
收藏  |  浏览/下载：18/0  |  提交时间：2019/12/11
Therapeutic Effect Of First-Line EGFR-TKIs Combined With Concurrent Cranial Radiotherapy On NSCLC Patients With EGFR Activating Mutation And Brain Metastasis: A Retrospective Study 期刊论文
ONCOTARGETS AND THERAPY, 2019, 卷号: 12, 页码: 8311-8318
作者:  An, Ning;  Wang, Haoyi;  Li, Ji;  Zhai, Xiaoyang;  Jing, Wang
收藏  |  浏览/下载：36/0  |  提交时间：2019/12/11
Great efficacy of afatinib on a patient with lung adenocarcinoma harboring uncommon EGFR delE709_T710insD mutations: a case report 期刊论文
ONCOTARGETS AND THERAPY, 2019, 卷号: 12, 页码: 7399-7404
作者:  An, Ning;  Wang, Haoyi;  Zhu, Hui;  Yan, Weiwei;  Jing, Wang
收藏  |  浏览/下载：13/0  |  提交时间：2019/12/11
Management of anlotinib-related adverse events in patients with advanced non-small cell lung cancer: Experiences in ALTER-0303 期刊论文
THORACIC CANCER, 2019, 卷号: 10, 期号: 3, 页码: 551-556
作者:  Si, Xiaoyan;  Zhang, Li;  Wang, Hanping;  Zhang, Xiaotong;  Wang, Mengzhao
收藏  |  浏览/下载：25/0  |  提交时间：2019/12/11
Investigating Novel Resistance Mechanisms to Third-Generation EGFR Tyrosine Kinase Inhibitor Osimertinib in Non-Small Cell Lung Cancer Patients 期刊论文
CLINICAL CANCER RESEARCH, 2018, 卷号: 24, 期号: 13, 页码: 3097-3107
作者:  Yang, Zhe;  Yang, Nong;  Ou, Qiuxiang;  Xiang, Yi;  Jiang, Tao
收藏  |  浏览/下载：6/0  |  提交时间：2019/12/11
Revisiting the molecular mechanism of acquired resistance to reversible tyrosine kinase inhibitors caused by EGFR gatekeeper T790M mutation in non-small-cell lung cancer 期刊论文
MEDICINAL CHEMISTRY RESEARCH, 2018, 卷号: 27, 期号: 9, 页码: 2160-2170
作者:  Zhao, Yan;  Jiao, Yingjie;  Sun, Fengzhe;  Liu, Xudong
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/11
Development of Bruton's Tyrosine Kinase Inhibitors for Rheumatoid Arthritis 期刊论文
CURRENT MEDICINAL CHEMISTRY, 2018, 卷号: 25, 期号: 42, 页码: 5847-5859
作者:  Lv, Jiahui
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/11
Targeting Bruton's tyrosine kinase for the treatment of B cell associated malignancies and autoimmune diseases: Preclinical and clinical developments of small molecule inhibitors 期刊论文
ARCHIV DER PHARMAZIE, 2018, 卷号: 351, 期号: 7
作者:  Zhang, Zhen;  Zhang, Daoguang;  Liu, Yang;  Yang, Dezhi;  Ran, Fansheng
收藏  |  浏览/下载：5/0  |  提交时间：2019/12/11
Current progress and outcomes of clinical trials on using epidermal growth factor receptor-tyrosine kinase inhibitor therapy in non-small cell lung cancer patients with brain metastases 期刊论文
慢性疾病与转化医学：英文版, 2017, 期号: 04
作者:  Ling-Ling Kong;  Lin-Lin Wang;  Li-Gang Xing;  Jin-Ming Yu
收藏  |  浏览/下载：7/0  |  提交时间：2019/12/11

©版权所有 ©2017 CSpace - Powered by CSpace